XENE XENON PHARMACEUTICALS INC
FollowStock (common), issuer CIK 1582313
206 managers (208 13F filers) reported a position in XENE shares at 2025-03-31, 76,712,560 shares in all. 20 filers opened a position and 22 filers sold out during the quarter.
- Managers
- 206
- 13F filers
- 208
- New
- 20
- Added
- 69
- Reduced
- 74
- Sold out
- 22
- Shares held by filers
- 76,712,560
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q1 2025
Filers in the available 13F reports with a share position at 2025-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Allworth Financial LP | 12 | $459 | <0.01% | 0 | 13F-HRTimeline |
| Bell Investment Advisors, Inc | 11 | $370 | <0.01% | -88 | 13F-HRTimeline |
| True Wealth Design, LLC | 9 | $302 | <0.01% | new | 13F-HRTimeline |
| GAMMA Investing LLC | 8 | $268 | <0.01% | -43 | 13F-HR/ATimeline |
| CONCOURSE FINANCIAL GROUP SECURITIES, I… | 0 | $0 | -2,000 | 13F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios. | |
| NOMURA ASSET MANAGEMENT CO LTDin group NOMURA ASSET MANAGEMENT CO LTD | 0 | $0 | 0% | 0 | 13F-HRTimelineGroupValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios. |